Skip to content
10-Q

Quarterly Report

Bausch Health Companies Inc. BHC

0000885590-26-000053

← back to feed
Filed
Apr 30, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 24, 2026 373.48M sh
Shares Diluted Q1 2026 · Mar 31, 2026 372.8M sh
Shares Diluted Q1 2026 · Mar 31, 2025 369.6M sh
Capex Q1 2026 · Mar 31, 2026 $109M
Capex Q1 2026 · Mar 31, 2025 $115M
Operating Cash Flow Q1 2026 · Mar 31, 2026 $230M
Operating Cash Flow Q1 2026 · Mar 31, 2025 $211M
Long Term Debt Q1 2026 · Mar 31, 2026 $19.88B
Long Term Debt Q1 2026 · Dec 31, 2025 $20.59B
Cash And Equivalents Q1 2026 · Mar 31, 2026 $1.3B
Cash And Equivalents Q1 2026 · Dec 31, 2025 $1.31B
Cash And Equivalents Q1 2026 · Mar 31, 2025 $1.13B
Stockholders Equity Q1 2026 · Mar 31, 2026 −$2.06B
Stockholders Equity Q1 2026 · Dec 31, 2025 −$554M
Current Liabilities Q1 2026 · Mar 31, 2026 $4.53B
Current Liabilities Q1 2026 · Dec 31, 2025 $4.18B
Total Liabilities Q1 2026 · Mar 31, 2026 $25.58B
Total Liabilities Q1 2026 · Dec 31, 2025 $25.99B
Current Assets Q1 2026 · Mar 31, 2026 $5.98B
Current Assets Q1 2026 · Dec 31, 2025 $6.16B
Total Assets Q1 2026 · Mar 31, 2026 $24.5B
Total Assets Q1 2026 · Dec 31, 2025 $26.37B
Eps Diluted Q1 2026 · Mar 31, 2026 −$3.82
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.16
Eps Basic Q1 2026 · Mar 31, 2026 −$3.82
Eps Basic Q1 2026 · Mar 31, 2025 −$0.16
Sga Expense Q1 2026 · Mar 31, 2026 $861M
Sga Expense Q1 2026 · Mar 31, 2025 $867M
Net Income Q1 2026 · Mar 31, 2026 −$1.42B
Net Income Q1 2026 · Mar 31, 2025 −$58M
Operating Income Q1 2026 · Mar 31, 2026 −$950M
Operating Income Q1 2026 · Mar 31, 2025 $276M
Revenue Q1 2026 · Mar 31, 2026 $2.52B
Revenue Q1 2026 · Mar 31, 2025 $2.26B